Showing results (1551-1560 of 1,680) with videos related to

Sort By:
Pageof 168
Circulation. Heart Failure|July 15, 2016
Marijuana and Listing for Heart Transplant: A Survey of Transplant ProvidersJonathan Neyer, Abhimanyu Uberoi, Michele Hamilton, et al.
Circulation. Heart Failure|June 16, 2016
Transcription Factor 7-like 2 Mediates Canonical Wnt/β-Catenin Signaling and c-Myc Upregulation in Heart FailureNing Hou, Bo Ye, Xiang Li, et al.
Circulation. Heart Failure|February 27, 2016
Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy: The Impact of Late Sodium Current Inhibition on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM) TrialIacopo Olivotto, Jennifer L Hellawell, Ramin Farzaneh-Far, et al.
Circulation. Heart Failure|March 11, 2016
Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist TrialEldrin F Lewis, Hae-Young Kim, Brian Claggett, et al.
Circulation. Heart Failure|January 1, 2015
Tumor necrosis factor: a mechanistic link between angiotensin-II-induced cardiac inflammation and fibrosisClemens Duerrschmid, JoAnn Trial, Yanlin Wang, et al.
Circulation. Heart Failure|August 22, 2015
Cardiac Resynchronization Therapy Reduces Subcellular Heterogeneity of Ryanodine Receptors, T-Tubules, and Ca2+ Sparks Produced by Dyssynchronous Heart FailureHui Li, Justin G Lichter, Thomas Seidel, et al.
Circulation. Heart Failure|October 24, 2014
Tumor necrosis factor receptor-associated factor 2 mediates mitochondrial autophagyKai-Chun Yang, Xiucui Ma, Haiyan Liu, et al.
Circulation. Heart Failure|June 12, 2013
Interactions of enhanced urocortin 2 and mineralocorticoid receptor antagonism in experimental heart failureMiriam T Rademaker, Christopher J Charles, M Gary Nicholls, et al.
Circulation. Heart Failure|July 27, 2013
Risk prediction models for mortality in ambulatory patients with heart failure: a systematic reviewAna C Alba, Thomas Agoritsas, Milosz Jankowski, et al.
Circulation. Heart Failure|January 26, 2018
Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure): Clinical and Prognostic AssociationsPeter van der Meer, Niels Grote Beverborg, Marc A Pfeffer, et al.
Pageof 168